Diabetes and Metabolism Journal

Korean Diabetes Association (대한당뇨병학회)
권호 표지
DOI QR코드

DOI QR Code

2011 Clinical Practice Guidelines for Type 2 Diabetes in Korea

  • Ko, Seung-Hyun (Division of Endocrinology & Metabolism, Department of Internal Medicine, The Catholic University of Korea) ;
  • Kim, Sung-Rea (Division of Endocrinology & Metabolism, Department of Internal Medicine, The Catholic University of Korea) ;
  • Kim, Dong-Joon (Department of Internal Medicine, Inje University College of Medicine) ;
  • Oh, Seung-Joon (Division of Endocrinology & Metabolism, Department of Internal Medicine, Kyung Hee University School of Medicine) ;
  • Lee, Hye-Jin (Division of Endocrinology, Department of Internal Medicine, Ewha Womans University School of Medicine) ;
  • Shim, Kang-Hee (Department of Diabetes Education, Samsung Medical Center) ;
  • Woo, Mi-Hye (Department of Clinical Nutrition, Kyung Hee University Medical Center) ;
  • Kim, Jun-Young (Department of Socialwork, Hallym University Kangnam Sacred Heart Hospital) ;
  • Kim, Nan-Hee (Department of Internal Medicine, Korea University College of Medicine) ;
  • Kim, Jae-Taik (Division of Endocrinology and Metabolism, Department of Internal Medicine, Chung-Ang University College of Medicine) ;
  • Kim, Chong-Hwa (Division of Endicrinology & Metabolism, Sejong General Hospital) ;
  • Kim, Hae-Jin (Department of Endocrinology and Metabolism, Ajou University School of Medicine) ;
  • Jeong, In-Kyung (Division of Endocrinology & Metabolism, Department of Internal Medicine, Kyung Hee University School of Medicine) ;
  • Hong, Eun-Kyung (Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine) ;
  • Cho, Jae-Hyoung (Division of Endocrinology & Metabolism, Department of Internal Medicine, The Catholic University of Korea) ;
  • Mok, Ji-Oh (Division of Endocrinology & Metabolism, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine) ;
  • Yoon, Kun-Ho (Division of Endocrinology & Metabolism, Department of Internal Medicine, The Catholic University of Korea) ;
  • Committee of Clinical Practice Guidelines, Committee of Clinical Practice Guidelines (Committee of Clinical Practice Guidelines) ;
  • Korean Diabetes Association, Korean Diabetes Association (Korean Diabetes Association)
  • Published : 2011.10.30
⟨ Previous Next ⟩

Abstract

As in other countries, type 2 diabetes is major health concern in Korea. A dramatic increase in the prevalence of type 2 diabetes and its chronic complications has led to an increase in health costs and economic burdens. Early detection of high risk individuals, hidden diabetic patients, and improvement in the quality of care for the disease are the first steps to mitigate the increase in prevalence. The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the '3rd Clinical Practice Guidelines' at the end of 2010. In the guidelines, the committee recommended active screening of high risk individuals for early detection and added the hemoglobin A1c level to the diagnostic criteria for type 2 diabetes based on clinical studies performed in Korea. Furthermore, the committee members emphasized that integrating patient education and self-management is an essential part of care. The drug treatment algorithm based on the degree of hyperglycemia and patient characteristics were also updated.

Keywords

References

  1. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, Zimmet P, Son HY. Epidemic obesity and type 2 diabetes in Asia. Lancet 2006;368:1681-8. https://doi.org/10.1016/S0140-6736(06)69703-1
  2. Kim DJ. The epidemiology of diabetes in Korea. Diabetes Metab J 2011;35:303-8. https://doi.org/10.4093/dmj.2011.35.4.303
  3. Statistics Korea: 2009 statistical results about cause of death. Available from: http://www.index.go.kr (updated 2011 Sep 5).
  4. Task Force Team for Basic Statistical Study of Korean Diabetes Mellitus. Report of Task Force Team for Basic Statistical Study of Korean Diabetes Mellitus: diabetes in Korea 2007. 1st ed. Seoul: Goldfishery; 2007.
  5. Oh JY, Lim S, Kim DJ, Kim NH, Kim DJ, Moon SD, Jang HC, Cho YM, Song KH, Park KS; Committee of the Korean Diabetes Association on the Diagnosis and Classification of Diabetes Mellitus. The diagnosis of diabetes mellitus in Korea: a pooled analysis of four community-based cohort studies. Diabet Med 2007;24:217-8. https://doi.org/10.1111/j.1464-5491.2007.02051.x
  6. Kim JH, Han MA, Park CJ, Park IG, Shin JH, Kim SY, Ryu SY, Bae HY. Evaluation of fasting plasma glucose as a screening for diabetes mellitus in middle-aged adults of Naju Country. Korean Diabetes J 2008;32:328-37. https://doi.org/10.4093/kdj.2008.32.4.328
  7. Oh JY, Lim S, Kim DJ, Kim NH, Kim DJ, Moon SD, Jang HC, Cho YM, Song KH, Ahn CW, Sung YA, Park JY, Shin C, Lee HK, Park KS; Committee of the Korean Diabetes Association on the Diagnosis and Classification of Diabetes Mellitus. A report on the diagnosis of intermediate hyperglycemia in Korea: a pooled analysis of four community-based cohort studies. Diabetes Res Clin Pract 2008;80:463-8. https://doi.org/10.1016/j.diabres.2008.01.022
  8. Choi KM, Lee J, Kim DR, Kim SK, Shin DH, Kim NH, Park IB, Choi DS, Baik SH. Comparison of ADA and WHO criteria for the diagnosis of diabetes in elderly Koreans. Diabet Med 2002;19:853-7. https://doi.org/10.1046/j.1464-5491.2002.00783.x
  9. Choi YH, Yoon KH, Cha BY, Lee KW, Son HY, Kang SK. Classification of diabetes mellitus according to NDDG and ADA diagnostic criteria and comparison of insulin secretion. Paper presented at: The 50th Annual Conference of the Korean As-sociation of Internal Medicine; 1998 Oct 23-24; Seoul, Korea.
  10. DJ, Song KE, Park JW, Cho HK, Lee KW, Huh KB. Clinical characteristics of Korean type 2 diabetic patients in 2005. Diabetes Res Clin Pract 2007;77 Suppl 1:S252-7. https://doi.org/10.1016/j.diabres.2007.01.067
  11. American Diabetes Association. Standards of medical care in diabetes--2010. Diabetes Care 2010;33 Suppl 1:S11-61. https://doi.org/10.2337/dc10-S011
  12. Hanas R, John G; International HbA1c Consensus Committee. 2010 consensus statement on the worldwide standardization of the hemoglobin A1C measurement. Diabetes Care 2010;33:1903-4. https://doi.org/10.2337/dc10-0953
  13. Song J, Kwon KC, Kim JH, Kim JW, Min WK, Lee SY, Lee EH, Jun SH, Choi TY. Annual report on external quality assessment in metabolic disorders in Korea (2008). J Lab Med Qual Assur 2009;31:143-59.
  14. Bae JC, Rhee EJ, Choi ES, Kim JH, Kim WJ, Yoo SH, Park SE, Park CY, Lee WY, Oh KW, Park SW, Kim SW. The cutoff value of HbA1c in predicting diabetes in Korean adults in a university hospital in Seoul. Korean Diabetes J 2009;33:503-10. https://doi.org/10.4093/kdj.2009.33.6.503
  15. Kim KS, Kim SK, Lee YK, Park SW, Cho YW. Diagnostic value of glycated haemoglobin HbA(1c) for the early detection of diabetes in high-risk subjects. Diabet Med 2008;25:997-1000. https://doi.org/10.1111/j.1464-5491.2008.02489.x
  16. Ku YH, Yoo SH, Jung HS, Lim S, Moon MK, Choi SH, Jang HC, Park KS, Kim SY, Lee HK, Cho YM. Diagnostic value of HbA1c different clinical setting with different prevelence of diabetes mellitus. Korean Diabetes J 2008;32(Suppl 8):S311.
  17. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103-17. https://doi.org/10.1016/0168-8227(95)01064-K
  18. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65. https://doi.org/10.1016/S0140-6736(98)07037-8
  19. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837- 53. https://doi.org/10.1016/S0140-6736(98)07019-6
  20. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS; American Diabetes Association; American College of Cardiology Foundation; American Heart Association. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care 2009;32:187-92. https://doi.org/10.2337/dc08-9026

Cited by

  1. Letter: Diabetic Polyneuropathy and Cardiovascular Complications in Type 2 Diabetic Patients (Diabetes Metab J 2011;35:390-6) vol.35, pp.5, 2011, https://doi.org/10.4093/dmj.2011.35.5.558
  2. Low Density Lipoprotein Cholesterol Target Goal Attainment Rate and Physician Perceptions about Target Goal Achievement in Korean Patients with Diabetes vol.35, pp.6, 2011, https://doi.org/10.4093/dmj.2011.35.6.628
  3. Higher Morning to Evening Ratio in Total Dose of Twice-Daily Biphasic Insulin Analog Might Be Effective in Achieving Glucose Control in Patients with Poorly Controlled Type 2 Diabetes vol.14, pp.6, 2011, https://doi.org/10.1089/dia.2011.0208
  4. Renal Hyperfiltration in Prediabetes Confirmed by Fasting Plasma Glucose and Hemoglobin A1c vol.34, pp.9, 2012, https://doi.org/10.3109/0886022x.2012.717516
  5. Body Mass Index and Waist Circumference According to Glucose Tolerance Status in Korea: The 2005 Korean Health and Nutrition Examination Survey vol.27, pp.5, 2011, https://doi.org/10.3346/jkms.2012.27.5.518
  6. The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone vol.36, pp.5, 2011, https://doi.org/10.4093/dmj.2012.36.5.371
  7. Smoking and Type 2 Diabetes Mellitus vol.36, pp.6, 2012, https://doi.org/10.4093/dmj.2012.36.6.399
  8. Prevalence of Diabetes and Prediabetes according to Fasting Plasma Glucose and HbA1c vol.37, pp.5, 2011, https://doi.org/10.4093/dmj.2013.37.5.349
  9. Metformin Based Dual-Combination Therapies in Drug Naïve Type 2 Diabetic Patients vol.37, pp.6, 2011, https://doi.org/10.4093/dmj.2013.37.6.429
  10. Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients vol.37, pp.6, 2011, https://doi.org/10.4093/dmj.2013.37.6.465
  11. The glycemic efficacies of insulin analogue regimens according to baseline glycemic status in Korean patients with type 2 diabetes: sub-analysis from the A1chieve® study vol.68, pp.11, 2011, https://doi.org/10.1111/ijcp.12482
  12. Association of Vitamin B 12 Deficiency and Metformin Use in Patients with Type 2 Diabetes vol.29, pp.7, 2011, https://doi.org/10.3346/jkms.2014.29.7.965
  13. Plasma Glucose Regulation and Mortality in Korea: A Pooled Analysis of Three Community-Based Cohort Studies vol.38, pp.1, 2011, https://doi.org/10.4093/dmj.2014.38.1.44
  14. Higher Prevalence and Awareness, but Lower Control Rate of Hypertension in Patients with Diabetes than General Population: The Fifth Korean National Health and Nutrition Examination Survey in 2011 vol.38, pp.1, 2011, https://doi.org/10.4093/dmj.2014.38.1.51
  15. Internet-Based Mentoring Program for Patients with Type 1 Diabetes vol.38, pp.2, 2011, https://doi.org/10.4093/dmj.2014.38.2.107
  16. The Relationship between BMI and Glycated Albumin to Glycated Hemoglobin (GA/A1c) Ratio According to Glucose Tolerance Status vol.9, pp.2, 2011, https://doi.org/10.1371/journal.pone.0089478
  17. Development of an HbA1c-Based Conversion Equation for Estimating Glycated Albumin in a Korean Population with a Wide Range of Glucose Intolerance vol.9, pp.4, 2011, https://doi.org/10.1371/journal.pone.0095729
  18. Non-HDL cholesterol is an independent risk factor for aspirin resistance in obese patients with type 2 diabetes vol.234, pp.1, 2014, https://doi.org/10.1016/j.atherosclerosis.2014.01.015
  19. Glycaemic and haemoglobin A1c thresholds for detecting diabetic retinopathy: The fifth Korea National Health and Nutrition Examination Survey (2011) vol.104, pp.3, 2011, https://doi.org/10.1016/j.diabres.2014.04.003
  20. Clinical Characteristics of Subjects with Sulfonylurea-Dependent Type 2 Diabetes vol.30, pp.4, 2011, https://doi.org/10.3803/enm.2015.30.4.509
  21. Intensive Individualized Reinforcement Education Is Important for the Prevention of Hypoglycemia in Patients with Type 2 Diabetes vol.39, pp.2, 2011, https://doi.org/10.4093/dmj.2015.39.2.154
  22. The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Understanding How Data Can Inform Clinical Practice in Korea vol.39, pp.3, 2011, https://doi.org/10.4093/dmj.2015.39.3.177
  23. Current Status of Management in Type 2 Diabetes Mellitus at General Hospitals in South Korea vol.39, pp.4, 2011, https://doi.org/10.4093/dmj.2015.39.4.307
  24. Cardiovascular Disease Predicts Severe Hypoglycemia in Patients with Type 2 Diabetes vol.39, pp.6, 2015, https://doi.org/10.4093/dmj.2015.39.6.498
  25. Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes vol.30, pp.1, 2011, https://doi.org/10.3904/kjim.2015.30.1.6
  26. Assessment of Cardiovascular Risk in Adults With Type 2 Diabetes and Metabolic Syndrome : Framingham Versus UKPDS Equations vol.41, pp.2, 2011, https://doi.org/10.1177/0145721715572154
  27. The Association between Chronic Kidney Disease and Diabetic Retinopathy: The Korea National Health and Nutrition Examination Survey 2008-2010 vol.10, pp.4, 2011, https://doi.org/10.1371/journal.pone.0125338
  28. Association between Self-Reported Smoking and Hemoglobin A1c in a Korean Population without Diabetes: The 2011–2012 Korean National Health and Nutrition Examination Survey vol.10, pp.5, 2011, https://doi.org/10.1371/journal.pone.0126746
  29. Assessment of glycemic control in patients with type 2 diabetes mellitus treated with metformin–sulfonylurea combination: Results of a multicenter, cross-sectional, observational study in Korea vol.6, pp.3, 2011, https://doi.org/10.1111/jdi.12284
  30. The Correlation between Hemoglobin A1c and Common Carotid Artery Intima Medial Thickness of Both Genders with Less Than 6.5% HbA1c Based on Ultrasound Measurement vol.15, pp.2, 2015, https://doi.org/10.15384/kjhp.2015.15.2.47
  31. Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review vol.16, pp.13, 2011, https://doi.org/10.1517/14656566.2015.1070827
  32. Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement vol.19, pp.5, 2011, https://doi.org/10.4103/2230-8210.163171
  33. Association between estimated blood glucose levels and glycated hemoglobin levels vol.31, pp.3, 2016, https://doi.org/10.3904/kjim.2016.101
  34. Relationship between metabolic syndrome and thyroid nodules in healthy Koreans vol.31, pp.1, 2011, https://doi.org/10.3904/kjim.2016.31.1.98
  35. Glycosylated Hemoglobin Threshold for Predicting Diabetes and Prediabetes from the Fifth Korea National Health and Nutrition Examination Survey vol.40, pp.2, 2011, https://doi.org/10.4093/dmj.2016.40.2.167
  36. Feasibility of a Patient-Centered, Smartphone-Based, Diabetes Care System: A Pilot Study vol.40, pp.3, 2011, https://doi.org/10.4093/dmj.2016.40.3.192
  37. Severe Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes vol.40, pp.3, 2011, https://doi.org/10.4093/dmj.2016.40.3.202
  38. A Potential Issue with Screening Prediabetes or Diabetes Using Serum Glucose: A Delay in Diagnosis vol.40, pp.5, 2011, https://doi.org/10.4093/dmj.2016.40.5.414
  39. Retrospective Observational Dose-Titration Study of Subjects with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on 15 mg of Pioglitazone vol.17, pp.1, 2016, https://doi.org/10.4093/jkd.2016.17.1.51
  40. Optimal Glycemic and Hemoglobin A1c Thresholds for Diagnosing Diabetes Based on Prevalence of Retinopathy in an Iranian Population vol.18, pp.8, 2011, https://doi.org/10.5812/ircmj.31254
  41. 당뇨병 교육자의 당뇨교육 경험: 내용분석적 접근 vol.30, pp.2, 2016, https://doi.org/10.5932/jkphn.2016.30.2.221
  42. Fasting plasma glucose concentrations for specified HbA1c goals in Korean populations: data from the Fifth Korea National Health and Nutrition Examination Survey (KNHANES V-2, 2011) vol.8, pp.None, 2011, https://doi.org/10.1186/s13098-016-0179-8
  43. Efficient Strategy to Identify Gene-Gene Interactions and Its Application to Type 2 Diabetes vol.14, pp.4, 2016, https://doi.org/10.5808/gi.2016.14.4.160
  44. Letter: Comparison of Age of Onset and Frequency of Diabetic Complications in the Very Elderly Patients with Type 2 Diabetes ( Endocrinol Metab 2016;31:416-23, Bong-Ki Lee et al.) vol.32, pp.1, 2011, https://doi.org/10.3803/enm.2017.32.1.140
  45. Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association vol.41, pp.5, 2011, https://doi.org/10.4093/dmj.2017.41.5.337
  46. Features of Long-Standing Korean Type 2 Diabetes Mellitus Patients with Diabetic Retinopathy: A Study Based on Standardized Clinical Data vol.41, pp.5, 2011, https://doi.org/10.4093/dmj.2017.41.5.393
  47. 제6기 국민건강영양조사를 토대로 분석한 한국 성인의 당뇨병과 빈혈 관계 vol.23, pp.1, 2011, https://doi.org/10.14373/jkda.2017.23.1.54
  48. 당뇨병 및 공복혈당장애 예측을 위한 당화혈색소 값 vol.49, pp.2, 2017, https://doi.org/10.15324/kjcls.2017.49.2.114
  49. Diagnostic criteria for diabetes in China: are we pushing too much beyond evidence? vol.71, pp.7, 2011, https://doi.org/10.1038/ejcn.2017.51
  50. Validation of a Newly Developed Equation for Estimating Serum Apolipoprotein B: Associations with Cardiovascular Disease Surrogate Markers in Koreans vol.58, pp.5, 2011, https://doi.org/10.3349/ymj.2017.58.5.975
  51. Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association vol.32, pp.6, 2011, https://doi.org/10.3904/kjim.2017.298
  52. Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment vol.8, pp.1, 2011, https://doi.org/10.1038/s41467-017-01682-2
  53. Patterns, control and complications of diabetes from a hospital based registry established in a low income country vol.17, pp.1, 2017, https://doi.org/10.1186/s12902-017-0179-1
  54. Diabetes Fact Sheet in Korea, 2016: An Appraisal of Current Status vol.42, pp.5, 2011, https://doi.org/10.4093/dmj.2018.0017
  55. Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass Index vol.42, pp.2, 2011, https://doi.org/10.4093/dmj.2018.42.2.137
  56. Distribution of glycated haemoglobin and its determinants in Korean youth and young adults: a nationwide population-based study vol.8, pp.None, 2018, https://doi.org/10.1038/s41598-018-20274-8
  57. The effectiveness, reproducibility, and durability of tailored mobile coaching on diabetes management in policyholders: A randomized, controlled, open-label study vol.8, pp.None, 2011, https://doi.org/10.1038/s41598-018-22034-0
  58. Discrepancies between Glycosylated Hemoglobin and Fasting Plasma Glucose for Diagnosing Impaired Fasting Glucose and Diabetes Mellitus in Korean Youth and Young Adults vol.43, pp.2, 2019, https://doi.org/10.4093/dmj.2018.0046
  59. Assessment of Safety and Effectiveness of Glaritus® (Wockhardt’s Insulin Glargine) in a Prospective, Multi-Centric Post Marketing Observational Study in Nepalese Having Ty vol.9, pp.2, 2011, https://doi.org/10.4236/ojemd.2019.92003
  60. 2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea vol.43, pp.4, 2019, https://doi.org/10.4093/dmj.2019.0137
  61. Lack of Association between Past Helicobacter pylori Infection and Diabetes: A Two-Cohort Study vol.11, pp.8, 2011, https://doi.org/10.3390/nu11081874
  62. Three-Dimensional Paper-Based Microfluidic Analytical Devices Integrated with a Plasma Separation Membrane for the Detection of Biomarkers in Whole Blood vol.11, pp.40, 2011, https://doi.org/10.1021/acsami.9b13644
  63. National trends in metformin-based combination therapy of oral hypoglycaemic agents for type 2 diabetes mellitus vol.75, pp.12, 2019, https://doi.org/10.1007/s00228-019-02751-9
  64. Discordance in prediction for prognosis of type 2 diabetes after metabolic surgery: comparison of the ABCD, DiaRem, and individualized metabolic surgery models vol.97, pp.6, 2011, https://doi.org/10.4174/astr.2019.97.6.309
  65. Sex-, Age-, and Metabolic Disorder-Dependent Distributions of Selected Inflammatory Biomarkers among Community-Dwelling Adults vol.44, pp.None, 2011, https://doi.org/10.4093/dmj.2019.0119
  66. Clinical Characteristics and Prevalence of Comorbidities according to Metformin Use in Korean Patients with Type 2 Diabetes vol.2020, pp.None, 2011, https://doi.org/10.1155/2020/9879517
  67. Comparison of effectiveness and drug cost between dipeptidyl peptidase‐4 inhibitor and biguanide as the first‐line anti‐hyperglycaemic medication among Japanese working generation wi vol.26, pp.1, 2020, https://doi.org/10.1111/jep.13171
  68. Efficacy and safety of insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Asia Pacific insulin‐naïve people with type 2 diabetes: The EDITION AP randomized controlled trial vol.22, pp.4, 2011, https://doi.org/10.1111/dom.13936
  69. Chronic Hyperglycemia before Spinal Cord Injury Increases Inflammatory Reaction and Astrogliosis after Injury: Human and Rat Studies vol.37, pp.9, 2011, https://doi.org/10.1089/neu.2019.6724
  70. Chronic Hyperglycemia before Spinal Cord Injury Increases Inflammatory Reaction and Astrogliosis after Injury: Human and Rat Studies vol.37, pp.9, 2011, https://doi.org/10.1089/neu.2019.6724
  71. Effect of different dietary patterns on glycemic control in individuals with type 2 diabetes mellitus: A systematic review vol.60, pp.12, 2020, https://doi.org/10.1080/10408398.2019.1624498
  72. Association of Cardiometabolic Multimorbidity Pattern with Dietary Factors among Adults in South Korea vol.12, pp.9, 2011, https://doi.org/10.3390/nu12092730
  73. Exploration of suitable pharmacodynamic parameters for acarbose bioequivalence evaluation: A series of clinical trials with branded acarbose vol.86, pp.11, 2011, https://doi.org/10.1111/bcp.14324
  74. Treatment Patterns of Type 2 Diabetes Assessed Using a Common Data Model Based on Electronic Health Records of 2000–2019 vol.36, pp.36, 2011, https://doi.org/10.3346/jkms.2021.36.e230